Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

April 1, 2008

Long term use of Allergan's Botox does not decrease efficacy

Analysis of: Efficay of Bolinum toxin does not sag over time | www.medscape.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford UniversitySunil Dhawan, MD 
Clinical Assistant Professor of Dermatology, Stanford University
Implications:  This article is important in that it lays to rest a misconception that long term repeated use of Botox ( Allergan) leads to decreased efficacy. Efficacy was maintained, and no neutralizing antibodies were found to Botox. This will reassure most users of Botox, and patients as well.

Analysis:   This will have a positive impact on Allergan's product Botox, and potentially on its future competitor, Reloxin, from Medicis. However, Reloxin has not been approved and no  similar efficacy studies have been done with this product to date.


Report a Concern

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics